VIA
RLAY icon

Virtus Investment Advisers’s Relay Therapeutics RLAY Stock Holding History

Virtus Investment Advisers’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$413K Sell
22,094
-11,863
-35% -$172K 0.1% 257
2026
Q1 		$338K Buy
33,957
+827
+2% +$7.4K 0.09% 262
2025
Q4 		$280K Buy
33,130
+148
+0.4% +$1.06K 0.08% 271
2025
Q3 		$172K Buy
32,982
+5,726
+21% +$21.8K 0.05% 329
2025
Q2 		$94.3K Sell
27,256
-7,089
-21% -$21.1K 0.03% 356
2025
Q1 		$90K Buy
+34,345
New +$135K 0.02% 434

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Virtus Investment Advisers's RLAY Position: Q2 2026 in Review

Virtus Investment Advisers reduced its Relay Therapeutics (RLAY) stake by 35% in Q2 2026, selling an estimated $172K and leaving 22,094 shares worth $413K. The position accounts for 0.1% of the portfolio, ranked #257.

Virtus Investment Advisers first reported a position in RLAY in Q1 2025 and has held it in 6 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Virtus Investment Advisers held 22,094 shares of Relay Therapeutics worth $413K as of Q2 2026.
  • Virtus Investment Advisers sold 11,863 Relay Therapeutics shares in Q2 2026, an estimated $172K.
  • Relay Therapeutics made up 0.1% of Virtus Investment Advisers's portfolio in Q2 2026, its #257 holding.
  • Virtus Investment Advisers first reported a position in Relay Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.